Could a diabetes drug curb cannabis cravings? small trial aims to find out
NCT ID NCT07265752
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether tirzepatide, a drug used for diabetes, can reduce cravings in people with severe cannabis use disorder. Six adults will receive either tirzepatide or a placebo injection and then be exposed to cannabis-related cues to measure craving intensity. The goal is to see if the drug helps control cravings, which could lead to better treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Tirzepatide (a diabetes drug) given as a weekly injection
- What this could lead to
- If it works, this could point toward a new treatment option for cannabis use disorder by reducing cravings.
- What could go wrong
- This is a very small pilot study with only 6 participants, so results may not apply broadly. It is also early-phase, so safety and effectiveness are not yet established.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANNABIS USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Genes may determine who gets hooked or psychotic from cannabis
- Could a natural brain chemical help tame cannabis cravings and lift mood?
- Brain scans reveal hidden links between depression, cannabis, and HIV in young adults
- Brain zaps could curb cannabis cravings in youth
- New pill aims to take the edge off quitting weed
- CBD vs. weed: can hemp help heavy users quit?